- Conditions
- Gonorrhea
- Interventions
- GSK2140944
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 106 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 12
- States / cities
- Fountain Valley, California • Los Angeles, California • Palm Springs, California + 8 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–41
of 41
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Chlamydia Trachomatis Infection, Neisseria Gonorrheae Infection, Asymptomatic Condition
- Interventions
- ID NOW™
- Diagnostic Test
- Lead sponsor
- Abbott Rapid Dx
- Industry
- Eligibility
- 14 Years and older
- Enrollment
- 7,100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- New Orleans, Louisiana
- Conditions
- Neisseria Gonorrheae Infection
- Interventions
- Investigational Reflex Test 1, Investigational Reflex Test 2, Investigational Reflex Test 3
- Diagnostic Test
- Lead sponsor
- Duke University
- Other
- Eligibility
- Not listed
- Enrollment
- 2,627 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 8
- States / cities
- San Francisco, California • Indianapolis, Indiana • Jackson, Mississippi + 5 more
- Conditions
- Gonorrhoea
- Interventions
- Cefixime
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Chlamydia Trachomatis Infection, Neisseria Gonorrheae Infection
- Interventions
- NeuMoDx CT/NG Assay, FDA-cleared NAATs
- Diagnostic Test
- Lead sponsor
- NeuMoDx Molecular, Inc.
- Industry
- Eligibility
- 14 Years to 80 Years
- Enrollment
- 4,017 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • North Miami, Florida • Orlando, Florida + 12 more
- Conditions
- Sexually Transmitted Diseases
- Interventions
- Visby Medical Men's STI PCR Test Kit
- Diagnostic Test
- Lead sponsor
- Visby Medical
- Industry
- Eligibility
- 14 Years and older · Male only
- Enrollment
- 507 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026
- U.S. locations
- 5
- States / cities
- Fort Lauderdale, Florida • Miami Lakes, Florida • Atlanta, Georgia + 2 more
- Conditions
- Bacterial Vaginosis, Vaginal Microbiome, Chlamydia Trachomatis Infection, Neisseria Gonorrheae Infection, Trichomonas Vaginitis
- Interventions
- Menstrual Cup
- Device
- Lead sponsor
- Rush University Medical Center
- Other
- Eligibility
- 15 Years to 35 Years · Female only
- Enrollment
- 408 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Sexually Transmitted Diseases
- Interventions
- Endocervical swab for detection of STI, Vaginal swab for detection of STI
- Diagnostic Test
- Lead sponsor
- OhioHealth
- Other
- Eligibility
- 16 Years and older · Female only
- Enrollment
- 17 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Chlamydial Infection, Gonococcal Infection, Trichomoniasis
- Interventions
- Click Sexual Health Test
- Diagnostic Test
- Lead sponsor
- Visby Medical
- Industry
- Eligibility
- 14 Years to 99 Years · Female only
- Enrollment
- 309 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019
- U.S. locations
- 5
- States / cities
- Fort Lauderdale, Florida • Saint Paul, Minnesota • St Louis, Missouri + 2 more
- Conditions
- Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection, Mycoplasma Genitalium Infection
- Interventions
- cobas® liat CT/NG/MG nucleic acid test, Standard of Care (SOC): Clinician's Standard Practice
- Diagnostic Test · Other
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 331 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 4
- States / cities
- San Francisco, California • Hamilton Square, New Jersey • Perth Amboy, New Jersey + 1 more
- Conditions
- Chlamydia, Gonorrhea
- Interventions
- Not listed
- Lead sponsor
- Siemens Healthcare Diagnostics Inc
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 2,296 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 7
- States / cities
- Birmingham, Alabama • Los Angeles, California • San Francisco, California + 4 more
- Conditions
- Neisseria Gonorrhoeae Infection
- Interventions
- Ciprofloxacin 500 mg
- Drug
- Lead sponsor
- University of Washington
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,800 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Sexually Transmitted Diseases, Gonorrhea, Chlamydia
- Interventions
- EVO100, Placebo
- Drug
- Lead sponsor
- Evofem Inc.
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 1,892 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2022
- U.S. locations
- 98
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Mesa, Arizona + 71 more
- Conditions
- Gonorrhoea
- Interventions
- Azithromycin, Gentamicin, Gemifloxacin
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 15 Years to 60 Years
- Enrollment
- 614 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 5
- States / cities
- Birmingham, Alabama • Los Angeles, California • San Francisco, California + 2 more
- Conditions
- Neisseria Gonorrhoeae Infection
- Interventions
- Meningococcal Group B Vaccine
- Biological
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 18 Years to 25 Years
- Enrollment
- 11 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- Gonorrhea, Neisseria Gonorrhoeae, Chlamydia Trachomatis
- Interventions
- Patient delivered partner therapy, Targeted public health partner services
- Other · Behavioral
- Lead sponsor
- University of Washington
- Other
- Eligibility
- 14 Years and older
- Enrollment
- 33,222 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2011
- U.S. locations
- 2
- States / cities
- Olympia, Washington • Seattle, Washington
- Conditions
- Gonococcal Infection
- Interventions
- Azithromycin, Ceftriaxone, Ciprofloxacin, Neisseria gonorrhoeae strain FA1090 A26, Neisseria gonorrhoeae strain FA7527
- Drug · Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 35 Years · Male only
- Enrollment
- 16 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina